<DOC>
	<DOCNO>NCT00174174</DOCNO>
	<brief_summary>The primary objective evaluate therapeutic effect excessive daytime sleepiness associate narcolepsy . Both subjective objective sleepiness patient assess experiment repeat measure .</brief_summary>
	<brief_title>Provigil ( Modafinil ) Study Taiwan Biotech Co .</brief_title>
	<detailed_description />
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Cataplexy</mesh_term>
	<mesh_term>Disorders Excessive Somnolence</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>Polysomnographic finding shorten sleep latency le 5 minute average Multiple Sleep Latency Test , two SOREM fulfil . Age 12 y/o 55 y/o . The liver kidney function within normal limit . Meeting strict criterion narcolepsy describe . Wash medication might enhance wakefulness affect nocturnal sleep two week prior experiment . Willingness comply protocol sign write Informed Consent . Patients whose hypersomnia cause severely sleep deprive , phase delay , suspect long sleeper . Patients concomitant neurological disorder psychiatric disorder . Patients sleeprelated breathe disorder whose apnea/hypopnea index ( AHI ) 5 pause per hour . Patients Restless Leg Syndrome &amp; Periodic Limbs Movements whose index 5 per hour . Patients pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2004</verification_date>
</DOC>